4.1 Article

Genetic Predictors of Depressive Symptoms in Cardiac Patients

Publisher

WILEY
DOI: 10.1002/ajmg.b.30824

Keywords

genetics; coronary disease; depression; endothelium

Funding

  1. National Institute of Health [HL077442]
  2. Fonds de la recherche en sante du Quebec (FRSQ)
  3. Heart and Stroke Foundation of Canada
  4. Canadian Institutes of Health Research
  5. Medical Research Council of Canada
  6. GlaxoSmithKline [POP-37744]
  7. Charles A. Dana Foundation
  8. Montreal Heart Institute Research Fund
  9. Pierre David Fund
  10. Fondation du Centre Hospitalier de l'Universite de Montreal

Ask authors/readers for more resources

Numerous studies suggest that the prevalence of depression is greater among cardiac patients than in the general population. However, little attention has been paid to the possibility of genetic contributions to depressive symptoms in cardiac patients. We conducted a candidate gene study focusing on genes related to inflammation, platelet aggregation, endothelial function and omega-3 fatty acid metabolism as predictors of depressive symptoms among 977 participants with established cardiovascular disease. Results suggested that genetic variation related to endothelial dysfunction is predictive of depressive symptoms and that endothelial dysfunction may be a novel mechanism contributing to depressive symptoms among cardiac patients. (C) 2008 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available